Gene Therapy
🇪🇺 EMAEMA news and analysis for pharmaceutical BD, investment, and market access
Unlock global gene therapy market insights. Stay ahead on regulatory approvals, clinical trials, and investment opportunities in this cutting-edge biotech sector.
Showing 1–12 of 26 articles
Quick answer
NovaPharmaNews Gene Therapy hub for EMA covers 26 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
CinnaGen's Zandoriah Achieves EU Approval for Osteoporosis Treatment
European Biotechs Innovate in Cell and Gene Therapy Manufacturing
Roche's Elevidys: A New Hope for DMD Gene Therapy Approval
First GLP-1 Gene Therapy Clinical Trial Approved in Europe
Roche's Elevidys Study Launch: Navigating EU Rejection
ISCT 2026: EU Manufacturing Innovations Day 1 Roundup
CRISPR Therapeutics Reports Q1 2026 Results as CASGEVY Gene Therapy Gains Global Regulatory Approval
Krystal Biotech Reports Strong Q1 2026 Results with VYJUVEK Global Expansion and Two Registrational Studies Pending
Vertex CASGEVY Gene Therapy Reaches 60,000+ Eligible Patients Across 10 Countries as Q1 2026 Results Show Global Expansion
Stoke Therapeutics Zorevunersen Shows Promise for Dravet Syndrome Treatment Ahead of Q1 2026 Results
uniQure AMT-130 Gene Therapy Advances Toward UK Approval for Huntington's Disease Treatment
EU Biopharma Clinical Trials: AI & Gene Therapy Surge
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.